Reason for request
Extension of indication
Clinical Benefit
| Substantial |
Substantial in type 1 diabetes in children aged 2 to 5 years. |
Clinical Added Value
| no clinical added value |
LANTUS provides no improvement in actual benefit (IAB V, non-existent) in the management of children aged 2 to 5 years with type 1 diabetes. |
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
VF4rM42cSYbp6n8m
